Alnylam Pharmaceuticals

$231.66

-$0.34 (-0.15%) As of 5:15 PM UTC today
1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
1,665
Employees1,665
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
1,665
Employees1,665

ALNY Key Statistics

Market cap
27.81B
Market cap27.81B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.96M
Average volume1.96M
High today
$234.51
High today$234.51
Low today
$228.08
Low today$228.08
Open price
$231.90
Open price$231.90
Volume
415.18K
Volume415.18K
52 Week high
$234.51
52 Week high$234.51
52 Week low
$117.58
52 Week low$117.58

Analyst ratings

62%

of 26 ratings
Buy
61.5%
Hold
34.6%
Sell
3.8%

ALNY Earnings

-$2.03
-$1.79
-$1.54
-$1.30
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
-$1.62 per share
Estimated-$1.62 per share
Actual
-$2.03 per share
Actual-$2.03 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.